Martí Farrera-Sal (Marti Farrera-Sal)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Gene Expression

Cancer Stem Cells

Machine Learning

Top Venues

Signal transduction and targeted therapy

Science advances

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Martí Farrera-Sal, Michael Schmueck-Henneresse
CAR-T overdrive: harnessing inosine for metabolic rewiring and stemness induction. Signal transduction and targeted therapy 9 (1) (2024)
Désirée Jacqueline Wendering, Leila Amini, Stephan Schlickeiser, Martí Farrera-Sal, Sarah Schulenberg, Lena Peter, Marco Mai, Tino Vollmer, Weijie Du, Maik Stein, Frederik Hamm, Alisier Malard, Carla Castro, Mingxing Yang, Ramon Ranka, Timo Rückert, Pawel Durek, Frederik Heinrich, Gilles Gasparoni, Abdulrahman Salhab, Jörn Walter, Dimitrios Laurin Wagner, Mir-Farzin Mashreghi, Sybille Landwehr-Kenzel, Julia K Polansky, Petra Reinke, Hans-Dieter Volk, Michael Schmueck-Henneresse
Effector memory-type regulatory T cells display phenotypic and functional instability. Science advances 10 (36) (2024)
Martí Farrera-Sal, Michael Schmueck-Henneresse
CAR-T overdrive: harnessing inosine for metabolic rewiring and stemness induction. Signal transduction and targeted therapy 9 (1) (2024)
Martí Farrera-Sal, Michael Schmueck-Henneresse
CAR-T overdrive: harnessing inosine for metabolic rewiring and stemness induction. Signal transduction and targeted therapy 9 (1) (2024)
Martí Farrera-Sal, Michael Schmueck-Henneresse
CAR-T overdrive: harnessing inosine for metabolic rewiring and stemness induction. Signal transduction and targeted therapy 9 (1) (2024)
Ayk Waldow, Laura-Sophie Beier, Janine Arndt, Simon Schallenberg, Claudia Vollbrecht, Philip Bischoff, Martí Farrera-Sal, Florian N Loch, Christian Bojarski, Michael Schumann, Lars Winkler, Carsten Kamphues, Lukas Ehlen, Jörg Piontek
cCPE Fusion Proteins as Molecular Probes to Detect Claudins and Tight Junction Dysregulation in Gastrointestinal Cell Lines, Tissue Explants and Patient-Derived Organoids. Pharmaceutics 15 (7) (2023)
Martí Farrera-Sal, Laura Moya-Borrego, Miriam Bazan-Peregrino, Ramon Alemany
Evolving Status of Clinical Immunotherapy with Oncolytic Adenovirus. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (11) (2021)
Guillem Pascual-Pasto, Miriam Bazan-Peregrino, Nagore G Olaciregui, Camilo A Restrepo-Perdomo, Ana Mato-Berciano, Daniela Ottaviani, Klaus Weber, Genoveva Correa, Sonia Paco, Monica Vila-Ubach, Maria Cuadrado-Vilanova, Helena Castillo-Ecija, Gaia Botteri, Laura Garcia-Gerique, Helena Moreno-Gilabert, Marta Gimenez-Alejandre, Patricia Alonso-Lopez, Martí Farrera-Sal, Silvia Torres-Manjon, Dolores Ramos-Lozano, Rafael Moreno, Isabelle Aerts, François Doz, Nathalie Cassoux, Elodie Chapeaublanc, Montserrat Torrebadell, Monica Roldan, Andrés König, Mariona Suñol, Joana Claverol, Cinzia Lavarino, Torres Carmen de, Ligia Fu, François Radvanyi, Francis L Munier, Jaume Catala, Jaume Mora, Ramón Alemany, Manel Cascalló, Guillermo L Chantada, Angel Montero Carcaboso
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01. Science translational medicine 11 (476) (2020)
Martí Farrera-Sal, Jana de Sostoa, Estela Nuñez-Manchón, Rafael Moreno, Cristina Fillat, Miriam Bazan-Peregrino, Ramon Alemany
Arming Oncolytic Adenoviruses: Effect of Insertion Site and Splice Acceptor on Transgene Expression and Viral Fitness. International journal of molecular sciences 21 (14) (2020)
Martí Farrera-Sal, Cristina Fillat, Ramon Alemany
Effect of Transgene Location, Transcriptional Control Elements and Transgene Features in Armed Oncolytic Adenoviruses. Cancers 12 (4) (2020)
Rafael Moreno, Carlos Alberto Fajardo, Martí Farrera-Sal, Ana Judith Perisé-Barrios, Álvaro Morales-Molina, Ahmed Abdullah Al-Zaher, Javier García-Castro, Ramon Alemany
Enhanced Antitumor Efficacy of Oncolytic Adenovirus-loaded Menstrual Blood-derived Mesenchymal Stem Cells in Combination with Peripheral Blood Mononuclear Cells. Molecular cancer therapeutics 18 (1) (2018)